Genetic characterization of invasive lobular breast cancer and its metastases

Genetic characterization of invasive lobular breast cancer and its metastases - ILC registry study

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00021618

Enrollment

5000

Registered

2021-01-18

Start date

2018-05-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C50.9

Interventions

Group 1: Patients with ILC are examined for somatic mutations, recruitment according to the interdisciplinary tumor conference, pathological examination by central laboratory Marburg

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: - dated approval signed by the patient or the legal representative - histological diagnosis of ILC histology in the primary tumor and/or the peripheric metastases

Exclusion criteria

Exclusion criteria: Age: <18 years

Design outcomes

Primary

Measure	Time frame
correlation of the mutation profile/pattern in the primary tumor and/or metastases	—

Secondary

Measure	Time frame
Mutation profiles‘ correlations with clinical parameters like TNM classification, therapy, imaging and course of disease	—

Countries

Germany

Contacts

Public ContactMaria Margarete Karsten

Charité Universitätsmedizin Berlin, Klinik für Gynäkologie mit Brustzentrum

maria-margarete.karsten@charite.de+49 30 450 664279

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026